Skip to main content
. 2024 Jan 9;13:1328519. doi: 10.3389/fcimb.2023.1328519

Table 3.

Minimum inhibitory concentration (mg/mL-1) of NLC against different bacterial strains.

Treatment mg/mL-1
Species After 2 months After 12 months
strains F1 F2 F6 F7 F8 F9 F10 F1
A. baumannii
OXA-23 1.19 ± 0.00 > 5.00 3.33 ± 2.89 1.60 ± 2.78 3.33 ± 1.44 > 4.90 > 5.00 > 4.76
POA4-28 0.80 ± 0.34 1.25 ± 0.00 1.25 ± 0.00 1.20 ± 0.00 1.25 ± 0.00 3.27 ± 2.83 2.08 ± 0.72 1.19 ± 0.00
65JF 1.19 ± 0.00 > 5.00 5.00 ± 0.00 3.20 ± 1.39 2.50 ± 0.00 > 4.90 > 5.00 2.38 ± 0.00
K. pneumoniae
ATCC700603 1.19 ± 0.00 > 5.00 5.00 ± 0.00 4.81 ± 0.00 5.00 ± 0.00 > 4.90 > 5.00 4.76 ± 0.00
Bactray 1.19 ± 0.00 > 5.00 2.50 ± 0.00 2.40 ± 0.00 2.50 ± 0.00 > 4.90 > 5.00 1.19 ± 0.00
Responsive 1.19 ± 0.00 > 5.00 2.50 ± 0.00 2.40 ± 2.41 2.50 ± 0.00 > 4.90 > 5.00 1.19 ± 0.00
P. aeruginosa
IMP-1 1.19 ± 0.00 > 5.00 2.50 ± 0.00 2.40 ± 0.00 2.50 ± 0.00 > 4.90 > 5.00 1.19 ± 0.00
PAO-1 1.19 ± 0.00 > 5.00 5.00 ± 0.00 4.81 ± 0.00 4.17 ± 1.44 > 4.90 > 5.00 2.38 ± 0.00